SEC Form 4 · accession 0001104659-26-092233
PHIBRO ANIMAL HEALTH CORP · PAHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Jack Bendheim
Officer — Executive Chairman · Director · 10% Owner
BFI Co., LLC
10% Owner
Period of report
Aug 4, 2026
Accepted (ET)
Aug 6, 2026 · 8:12 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001069899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1,F2 | Aug 4, 2026 | J | 2,303 | $36.599 | D | 14,537 | D | |
| Class A Common StockF3 | holding | — | — | — | 56,152 | I | See |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon the receipt of Class A Common Stock in connection with the vesting and settlement of restricted stock units.
- F2The reported securities are directly held by Jack Bendheim.
- F3The reported securities are directly held by BFI Co., LLC ("BFI"). Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.